Status:
COMPLETED
Implants Placement with Simultaneous Soft Tissue Augmentation Using a Collagen Matrix Compared to Connective Tissue Graft: a Pilot Study
Lead Sponsor:
Saint-Joseph University
Conditions:
Soft Tissue Thickness Arround Implants
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background: To our knowledge, no study evaluated the use of VCMX at multiple implant sites and compared its efficacy and safety to a SCTG with the same dimensions. Therefore, we propose in the present...
Eligibility Criteria
Inclusion
- Adults ;18 years old.
- Patients with adequate oral hygiene (FMPI\<20% and FMBI\<20%).
- Healed implant sites (tooth extraction at least 8 to 12 weeks before enrolment).
- Patients who need prosthetic rehabilitation of at least two implants in the left and right posterior mandibular area.
- Inadequate amount of soft tissue where the implants are planned to be placed: thin mucosal tissues covering the edentulous alveolar ridge.
- Compliant patients are willing to sign an informed consent.
Exclusion
- Uncontrolled periodontal disease.
- Heavy smoker (\>10 cigarettes per day).
- General contraindications for dental surgical treatment.
- Insufficient bone volume for implant placement requiring bone augmentation procedures.
- History of malignancy, radiotherapy, or chemotherapy for malignancy within the past 5 years.
- Pregnancy or breastfeeding.
- Previous and concurrent medication affecting bone and mucosal healing.
- Disease affecting bone and connective tissue metabolism.
- Immediate implant placement.
Key Trial Info
Start Date :
October 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT06585813
Start Date
October 10 2022
End Date
June 20 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint-Joseph University
Beirut, Beyrouth, Lebanon